MISSISSAUGA, Ontario, March 25 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. (OTC Bulletin Board:CGNH.ob - News), a developer of technology and products targeting the Point-Of-Care (POC) segment of the IVD market announced today that the Company has entered into lock-up agreements with its directors (other than Dr. Yahia Gawad who previously entered into a lock-up agreement with the Company) pursuant to which the directors agreed to lock-up 38,759,113 shares of the Company’s common stock held directly and indirectly by the directors through “Exchangeable Shares” in the Company’s wholly-owned Ontario, Canada subsidiary, CardioGenics ExchangeCo Inc. (“ExchangeCo”). ExchangeCo and WeirFoulds LLP (as “trustee” under that certain Voting and Exchange Trust Agreement dated July 6, 2009 among the Company, ExchangeCo and WeirFoulds LLP) are also parties to these lock-up agreements.
